U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday.
The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The S&P 500 also fell, dropping, 0.08% to 4,771.01.
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.
Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
MicroAlgo, Inc. (NASDAQ: MLGO) announced the quantum shield distributed ledger technology (QSDLT), designed to provide a secure foundation for Bitcoin (CRYPTO: BTC)
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday.
The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P 500 also rose, gaining, 0.06% to 4,777.57.
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher Wednesday after the company announced the FDA approval of its pegfilgrastim delivery device, Udenyca Onbody.
Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating successful oral delivery of two lipid nanocrystal (LNC)-formulated small single-strand oligonucleotides targeting inflammatory cytokines TNFα and IL-17
Beyond Cancer Ltd, an affiliate of Beyond Air Inc (NASDAQ: XAIR), announced that the Phase 1 Study evaluating ultra-high concentration nitric oxide (UNO) in advanced, relapsed or refractory unresectable, primary or metastatic cutaneous and subcutaneous solid tumors has cleared the